Department of Pathology, Cardiovascular & Thoracic Division, Seth GS Medical College & KEM Hospital, Mumbai, India.
Cardiovasc Pathol. 2013 Jan-Feb;22(1):70-4. doi: 10.1016/j.carpath.2012.06.003. Epub 2012 Aug 3.
Giant cell myocarditis (GCM) is a rare disorder that is known primarily from North American, European, and Japanese case series. The clinical and pathological features of GCM in India have not been reported.
We reviewed the pathology records from 1994 to 2010 from a tertiary care referral hospital in Mumbai for all cases of pathologically confirmed GCM. Gross and microscopic histological features and clinical characteristics of the GCM cases were described and qualitatively compared to GCM case series from other regions of the world.
The 12 cases of GCM constituted 0.005% of all autopsies and 0.8% of myocarditis cases. Gross pathological features included variably dilated chambers in 8/12 cases with multifocal involvement of the myocardium. Three had regional hypertrophy associated with marked lymphocytic infiltrate. There were unique cases of a posterior wall rupture with hemopericardium and a case with multiple epicardial inflammatory sessile polyps. A novel possible trigger was suggested by a positive serologic test for leptospirosis in one case. The clinical features including age, gender, presenting symptoms, and prognosis resemble those reported in autopsy-based case series from other regions.
GCM affects patients in India at approximately the same rate as in Europe and Japan. The clinical and histological features of GCM are similarly severe and suggest a heart-specific autoimmune reaction.
巨细胞心肌炎(GCM)是一种罕见的疾病,主要见于北美、欧洲和日本的病例系列。印度的 GCM 的临床和病理特征尚未报道。
我们回顾了 1994 年至 2010 年期间孟买一家三级医疗转诊医院的病理学记录,以寻找所有经病理证实的 GCM 病例。描述了 GCM 病例的大体和微观组织学特征以及临床特征,并与来自世界其他地区的 GCM 病例系列进行了定性比较。
12 例 GCM 占所有尸检的 0.005%,占心肌炎病例的 0.8%。大体病理特征包括 8/12 例心室不同程度扩张,心肌多灶性受累。有 3 例与明显淋巴细胞浸润相关的区域性肥厚。有一个独特的后侧壁破裂伴血心包和一个多发性心外膜炎性息肉的病例。一例病例的钩端螺旋体病血清学检测阳性提示可能存在新的触发因素。临床特征包括年龄、性别、首发症状和预后与其他地区尸检为基础的病例系列报道相似。
GCM 在印度的发病率与欧洲和日本大致相同。GCM 的临床和组织学特征同样严重,提示存在心脏特异性自身免疫反应。